Literature DB >> 18639454

Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.

Jessica K DeMartino1, Joie Garfunkle, Dustin G Hochstatter, Benjamin F Cravatt, Dale L Boger.   

Abstract

A series of C4 substituted alpha-ketooxazoles were examined as inhibitors of the serine hydrolase fatty acid amide hydrolase in efforts that further define and generalize a fundamental substituent effect on enzyme inhibitory potency. Thus, a plot of the Hammett sigma(m) versus -logK(i) provided a linear correlation (R(2)=0.90) with a slope of 3.37 (rho=3.37), that is of a magnitude that indicates that of the electron-withdrawing character of the substituent dominates its effects (a one unit change in sigma(m) provides a >1000-fold change in K(i)).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18639454      PMCID: PMC2582052          DOI: 10.1016/j.bmcl.2008.06.084

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  54 in total

1.  Activity-based protein profiling: the serine hydrolases.

Authors:  Y Liu; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates.

Authors:  Giulio G Muccioli; Nicola Fazio; Gerhard K E Scriba; Wolfgang Poppitz; Fabio Cannata; Jacques H Poupaert; Johan Wouters; Didier M Lambert
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

3.  Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase.

Authors:  D G Deutsch; R Omeir; G Arreaza; D Salehani; G D Prestwich; Z Huang; A Howlett
Journal:  Biochem Pharmacol       Date:  1997-02-07       Impact factor: 5.858

4.  Functional disassociation of the central and peripheral fatty acid amide signaling systems.

Authors:  Benjamin F Cravatt; Alan Saghatelian; Edward G Hawkins; Angela B Clement; Michael H Bracey; Aron H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

5.  Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Authors:  Marco Mor; Silvia Rivara; Alessio Lodola; Pier Vincenzo Plazzi; Giorgio Tarzia; Andrea Duranti; Andrea Tontini; Giovanni Piersanti; Satish Kathuria; Daniele Piomelli
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

6.  An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase.

Authors:  M P Patricelli; J E Patterson; D L Boger; B F Cravatt
Journal:  Bioorg Med Chem Lett       Date:  1998-03-17       Impact factor: 2.823

Review 7.  Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.

Authors:  Benjamin F Cravatt; Aron H Lichtman
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

8.  Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.

Authors:  Mikko J Myllymäki; Susanna M Saario; Antti O Kataja; Joel A Castillo-Melendez; Tapio Nevalainen; Risto O Juvonen; Tomi Järvinen; Ari M P Koskinen
Journal:  J Med Chem       Date:  2007-08-01       Impact factor: 7.446

9.  Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Authors:  Christophe Hardouin; Michael J Kelso; F Anthony Romero; Thomas J Rayl; Donmienne Leung; Inkyu Hwang; Benjamin F Cravatt; Dale L Boger
Journal:  J Med Chem       Date:  2007-06-09       Impact factor: 7.446

10.  Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Authors:  F Scott Kimball; F Anthony Romero; Cyrine Ezzili; Joie Garfunkle; Thomas J Rayl; Dustin G Hochstatter; Inkyu Hwang; Dale L Boger
Journal:  J Med Chem       Date:  2008-02-05       Impact factor: 7.446

View more
  14 in total

Review 1.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

Review 2.  The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Katerina Otrubova; Cyrine Ezzili; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2011-06-28       Impact factor: 2.823

3.  Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-02-28       Impact factor: 15.419

4.  Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.

Authors:  Cyrine Ezzili; Mauro Mileni; Nicholas McGlinchey; Jonathan Z Long; Steven G Kinsey; Dustin G Hochstatter; Raymond C Stevens; Aron H Lichtman; Benjamin F Cravatt; Edward J Bilsky; Dale L Boger
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

5.  α-Ketoheterocycle-based Inhibitors of Fatty Acid Amide Hydrolase (FAAH).

Authors:  Katerina Otrubova; Dale L Boger
Journal:  ACS Chem Neurosci       Date:  2011-12-20       Impact factor: 4.418

6.  N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases.

Authors:  Katerina Otrubova; Shreyosree Chatterjee; Srijana Ghimire; Benjamin F Cravatt; Dale L Boger
Journal:  Bioorg Med Chem       Date:  2019-03-11       Impact factor: 3.641

7.  Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Authors:  Katerina Otrubova; Monica Brown; Michael S McCormick; Gye W Han; Scott T O'Neal; Benjamin F Cravatt; Raymond C Stevens; Aron H Lichtman; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-04-12       Impact factor: 15.419

8.  X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; F Scott Kimball; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

9.  Discovery libraries targeting the major enzyme classes: the serine hydrolases.

Authors:  Katerina Otrubova; Venkat Srinivasan; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2014-06-27       Impact factor: 2.823

10.  α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.

Authors:  Katharine K Duncan; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem       Date:  2014-03-18       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.